These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33661283)

  • 1. Functional Relevance of Hyper-Reflectivity in Macular Telangiectasia Type 2.
    Tzaridis S; Friedlander M;
    Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):6. PubMed ID: 33661283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2.
    Mukherjee D; Lad EM; Vann RR; Jaffe SJ; Clemons TE; Friedlander M; Chew EY; Jaffe GJ; Farsiu S;
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO291-BIO299. PubMed ID: 28973315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilayer Retinal Correspondence of the Structural and Vascular Anomalies in Eyes With Early Macular Telangiectasia Type 2.
    Krivosic V; Dobbels Z; Duliere C; Zureik A; Tadayoni R; Gaudric A
    Invest Ophthalmol Vis Sci; 2024 Sep; 65(11):24. PubMed ID: 39283616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2.
    Heeren TFC; Kitka D; Florea D; Clemons TE; Chew EY; Bird AC; Pauleikhoff D; Charbel Issa P; Holz FG; Peto T
    Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S20-S26. PubMed ID: 28541959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.
    Pauleikhoff D; Bonelli R; Dubis AM; Gunnemann F; Rothaus K; Charbel Issa P; Heeren TF; Peto T; Clemons TE; Chew EY; Bird AC; Sallo FB;
    Acta Ophthalmol; 2019 Nov; 97(7):e998-e1005. PubMed ID: 30968592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal cavitations in macular telangiectasia type 2 (MacTel): longitudinal structure-function correlations.
    Cai CX; Choong J; Farsiu S; Chiu SJ; Chew EY; Jaffe GJ
    Br J Ophthalmol; 2021 Jan; 105(1):109-112. PubMed ID: 32152145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating Retinal Sensitivity Using Optical Coherence Tomography With Deep-Learning Algorithms in Macular Telangiectasia Type 2.
    Kihara Y; Heeren TFC; Lee CS; Wu Y; Xiao S; Tzaridis S; Holz FG; Charbel Issa P; Egan CA; Lee AY
    JAMA Netw Open; 2019 Feb; 2(2):e188029. PubMed ID: 30735236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.
    Peto T; Heeren TFC; Clemons TE; Sallo FB; Leung I; Chew EY; Bird AC
    Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S8-S13. PubMed ID: 28505012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binocular Inhibition of Reading in Macular Telangiectasia Type 2.
    Tzaridis S; Herrmann P; Charbel Issa P; Degli Esposti S; Wagner SK; Fruttiger M; Egan C; Rubin G; Holz FG; Heeren TFC
    Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3835-3841. PubMed ID: 31529080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive multi-imaging biomarkers relevant for visual acuity in idiopathic macular telangiectasis type 1.
    Guo J; Tang W; Ye X; Wu H; Xu G; Liu W; Zhang Y
    BMC Ophthalmol; 2018 Mar; 18(1):69. PubMed ID: 29506510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microperimetry Features of Geographic Atrophy Identified With En Face Optical Coherence Tomography.
    Pilotto E; Convento E; Guidolin F; Abalsamo CK; Longhin E; Parrozzani R; Midena E
    JAMA Ophthalmol; 2016 Aug; 134(8):873-9. PubMed ID: 27253760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive optics microperimetry and OCT images show preserved function and recovery of cone visibility in macular telangiectasia type 2 retinal lesions.
    Wang Q; Tuten WS; Lujan BJ; Holland J; Bernstein PS; Schwartz SD; Duncan JL; Roorda A
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):778-86. PubMed ID: 25587056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-stage macular telangiectasia type 2 vascular abnormalities are associated with interdigitation zone disruption.
    Ong JX; Zandi R; Fawzi AA
    PLoS One; 2021; 16(11):e0259811. PubMed ID: 34767582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.
    Sallo FB; Leung I; Clemons TE; Peto T; Chew EY; Pauleikhoff D; Bird AC;
    Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S27-S32. PubMed ID: 28541963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular Pigment Distribution as Prognostic Marker for Disease Progression in Macular Telangiectasia Type 2.
    Müller S; Charbel Issa P; Heeren TFC; Thiele S; Holz FG; Herrmann P
    Am J Ophthalmol; 2018 Oct; 194():163-169. PubMed ID: 30053477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
    Pauleikhoff D; Gunnemann F; Book M; Rothaus K
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2.
    Krivosic V; Lavia C; Aubineau A; Tadayoni R; Gaudric A
    Ophthalmol Retina; 2021 Jun; 5(6):562-570. PubMed ID: 32956858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifocal electroretinography in patients with macular telangiectasia type 2.
    Goel N; Kumari A; Kumar S; Mehta A
    Doc Ophthalmol; 2020 Aug; 141(1):15-21. PubMed ID: 31912262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCOTOMA CHARACTERISTICS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 7-The MacTel Research Group.
    Vujosevic S; Heeren TFC; Florea D; Leung I; Pauleikhoff D; Sallo F; Bird A; Peto T
    Retina; 2018 Jan; 38 Suppl 1():S14-S19. PubMed ID: 28609329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.
    Heeren TFC; Chew EY; Clemons T; Fruttiger M; Balaskas K; Schwartz R; Egan CA; Charbel Issa P;
    Ophthalmology; 2020 Nov; 127(11):1539-1548. PubMed ID: 32586743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.